4//SEC Filing
Nexvet Biopharma plc 4
Accession 0001171000-17-000053
CIK 0001618561operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 1:39 PM ET
Size
7.2 KB
Accession
0001171000-17-000053
Insider Transaction Report
Form 4
HORN JURGEN
Chief Product Development Ofcr
Transactions
- Exercise/Conversion
Restricted Share Units
2017-07-01−15,750→ 47,250 totalExercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (15,750 underlying) - Exercise/Conversion
Ordinary Shares
2017-07-01$0.13/sh+15,750$1,969→ 15,750 total
Footnotes (1)
- [F1]15,750 of the Restricted Share Units vested and became convertible on 7/1/17 and 15,750 of the Restricted Share Units shall vest and become convertible on each of 7/1/18, 7/1/19 and 7/1/20, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.
Documents
Issuer
Nexvet Biopharma plc
CIK 0001618561
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001618561
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 1:39 PM ET
- Size
- 7.2 KB